Transfusion Library

No longer posting on X. Follow us on other social media.

Transfusion Evidence Library provides access to evidence-based publications on Transfusion Medicine

[Transfusion Library @TransfusionLib]

The #Transfusion Evidence Round-Up: Best of the TEL 2024 is out!
See all the top articles and listen to the podcast here:
https://t.co/kzpP2rn6PG
https://t.co/HJwm3UxqJ5

[NHS Blood+Transplant @NHSBT]

There is an urgent need for blood - especially O negative and B negative blood types.

We are calling on blood donors to book an appointment to donate as soon as possible. There are 11,000 appointment slots that need to be filled to help save lives.

➡️ https://t.co/vRyum7QrfL

[NHSBT Therapeutic Apheresis Services @NHSBTTAS]

An exciting new post is available that offers the opportunity to become a Locum Consultant Haematologist with an interest in Advanced Cellular Therapeutics.

You will be a key member of both NHS Blood and Transplant (NHSBT) and Bedfordshire Hospitals NHS Foundation Trust teams.

[NI Blood Transfusion @GiveBloodNI]

No time like the present 📅

Thousands of people across #NorthernIreland need donated blood to help them overcome, or live well, with cancer or various other illnesses 🩸❤️

Please give blood 🙏 Book now at https://t.co/tlVCbYnhOu

#GiveBlood #SaveLives #BloodDonation #Lifesaver

[Stem Cell Evidence @evidencestemc]

New from #StemCellEvidence:

Measurable residual mutated IDH1 before allogeneic transplant for acute myeloid leukemia
by Gui et al.
https://t.co/RVLTdzXpGT

[Stem Cell Evidence @evidencestemc]

New from #StemCellEvidence:

Immunological reconstitution and infections after alloHCT - a comparison between post-transplantation cyclophosphamide, ATLG and non-ATLG based GvHD prophylaxis
by Meyer et al.
https://t.co/IFJzh0dXhh

[Stem Cell Evidence @evidencestemc]

From the #StemCellEvidence Alert:

Impact of cytopenias and early versus late treatment with ruxolitinib in patients with steroid-refractory acute or chronic graft-versus-host disease
by Mahmoudjafari et al.
https://t.co/WHVi9gse6q

[Transfusion Library @TransfusionLib]

From the #Transfusion Evidence Round-Up: Best of the TEL 2024:

Efficacy and safety of #tranexamicacid in acute traumatic brain injury: A #metaanalysis of randomized controlled trials
by Zhang and Liu
https://t.co/8u0y2pUEZY

[Transfusion Library @TransfusionLib]

New from the #Transfusion Evidence Round-Up: Best of the TEL 2024:

A cost-effectiveness analysis of early detection and bundled treatment of postpartum hemorrhage alongside the E-MOTIVE trial
by Williams et al.
https://t.co/B10xkhDj2X

[Transfusion Library @TransfusionLib]

From the #Transfusion Evidence Round-Up: Best of the TEL 2024:

Efficacy and safety of #tranexamicacid in acute traumatic brain injury: A #metaanalysis of randomized controlled trials
by Zhang and Liu
https://t.co/8u0y2pVcPw

[Transfusion Library @TransfusionLib]

New from the #Transfusion Evidence Round-Up: Best of the TEL 2024:

A cost-effectiveness analysis of early detection and bundled treatment of postpartum hemorrhage alongside the E-MOTIVE trial
by Williams et al.
https://t.co/B10xkhDQSv

[Transfusion Library @TransfusionLib]

From the #Transfusion Evidence Round-Up: Best of the TEL 2024:

Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury
by Turgeon et al.
https://t.co/O6lvFNTpge

[Transfusion Library @TransfusionLib]

Thank you @ISBTCO volunteers and staff and @sritransfusion for all your hard work with the Transfusion Evidence Round-Ups during 2024!

[Transfusion Library @TransfusionLib]

From the #Transfusion Evidence Round-Up: Best of the TEL 2024:

Liberal or Restrictive Transfusion Strategy in Patients with Traumatic Brain Injury
by Turgeon et al.
https://t.co/O6lvFNTX5M

[Stem Cell Evidence @evidencestemc]

New from #StemCellEvidence:

Itacitinib for Prevention of Graft-Versus-Host Disease and Cytokine Release Syndrome in Haploidentical Transplantation
by Abboud et al.
https://t.co/FuUkWBtrU5

[Transfusion Library @TransfusionLib]

New from the #Transfusion Evidence Round-Up: Best of the TEL 2024:

Early Cold Stored Platelet Transfusion Following Severe Injury: A Randomized Clinical Trial
by Sperry et al.
https://t.co/nXKBG2xk7v

[Transfusion Library @TransfusionLib]

From the #Transfusion Evidence Round-Up Best of the TEL 2024:

Darbepoetin alfa to reduce transfusion episodes in infants with haemolytic disease of the fetus and newborn who are treated with intrauterine transfusions in the Netherlands (...)
by Ree et al
https://t.co/T2WYyTlRlX

[Transfusion Library @TransfusionLib]

New from the #Transfusion Evidence Round-Up: Best of the TEL 2024:

Two-year outcomes following a randomised platelet transfusion trial in preterm infants
by Moore et al.
https://t.co/vwUfQwaLW8

[Transfusion Library @TransfusionLib]

From the #Transfusion Evidence Round-Up: Best of the TEL 2024:

Prehospital #tranexamicacid is associated with a survival benefit without an increase in complications: Results of two harmonized randomized clinical trials
by Mazzei et al.
https://t.co/cZZRpDoPCe

[Transfusion Library @TransfusionLib]

New from the #Transfusion Evidence Round-Up: Best of the TEL 2024:

#MetaAnalysis and Metaregression of the Treatment Effect of Intravenous Iron in Iron-Deficient Heart Failure
by Martens et al.
https://t.co/bytBUtNYdd

[Transfusion Library @TransfusionLib]

From the #Transfusion Evidence Round-Up: Best of the TEL 2024:

Andexanet for Factor Xa Inhibitor-Associated Acute Intracerebral Hemorrhage
by Connolly et al.
https://t.co/PdcgvStQyS